Our scientific and medical strategy
Preventive healthcare is essential, urgent, effective and cost-efficient, with the most compelling results in terms of healthy life expectancy, quality of life and controlled cost for the individual, insurers and society. We must therefore tackle collectively, as early as possible, the most preventable and/or most treatable diseases: cardiovascular and metabolic conditions, cancers, neurodegenerative diseases and pathological ageing.
To succeed in the prevention revolution, Zoī invests in research, innovation and technology, with AI in support. For a genuine leap towards a healthy future and to correct individual life trajectories, we must « turn back the clock on health interventions », that is, address people as early as possible in their life journey.
First step · ages 40 to 70
Preventive medicine and its strategy of screening for existing but still silent pathologies. In this population, we aim for excellence in the early diagnosis of chronic diseases: they are already present, but silent.
To avoid incidentalomas and overmedicalisation, we use the best technologies, grounded in science and the most recent publications. This is, for example, why we make a point of not offering stress tests, which are less sensitive than coronary CT or stress cardiac MRI. We work with one of the best clinics in France for specialised imaging and interventional cardiology. Diseases detected at an early stage, such as cancers, have a far better prognosis.
Every detection is accompanied by a referral towards a care pathway that combines efficiency for the healthcare system with comfort for the patient. This referral is rigorously justified: we have no interest whatsoever in performing additional procedures or consultations. Everything prescribed is therefore the result of a purely medical analysis.
Second step · ages 18 to 40
Preventive medicine and its strategy of systematically looking for known risk factors, in young adults. We detect numerous risk factors for cardiovascular, metabolic, oncological and neurodegenerative diseases.
This is the ideal stage to correct trajectories early — and therefore with less effort — issue the best recommendations, treat if necessary, deeply change individual behaviours, and support and adapt health-promoting habits. It is at this period of life that the health trajectory becomes decisive, and that intervention is the most effective and the most cost-efficient.
Third step · the youngest
The future lies in preserving health capital and optimising health among the youngest. This is the role of functional medicine, of strengthening physical activity, of primary prevention, of nutrition, of stopping (or not adopting) behaviours harmful to health, of balancing oxidative stress and fighting low-grade inflammation.
It is important to consider the patient as a whole. The same patient may, for instance, be at the third step for atheromatous disease, and at the first step for oncological risk.
Our approach
We offer an original and innovative approach, rigorous and humanist, combining the latest advances in preventive medicine, the biology of ageing, health technologies, data science and behavioural science.
Grounded in evidence and demographic trends, this approach continuously draws on medical innovation and recent scientific publications, and feeds numerous research activities through collaborations with the best academic teams in France and abroad.
This proactive and innovative approach to prevention and early detection of risk factors and diseases aims to restore an optimal state of health as quickly as possible and to support people in the lasting adoption of health-promoting behaviours, with an improvement in quality of life and, ultimately, in healthy life expectancy, thanks to our app that supports everyday efforts and to tailored, personalised nursing and medical follow-up. One of the keys to adherence to recommendations is delivering a quality experience: this is why we are proud that the level of satisfaction measured among our members is excellent.
All our healthcare professionals develop active and empathetic listening, essential to building a lasting relationship of trust. The general practitioners or specialists concerned are informed of the results and of the rationale for the prescription, in order to ensure continuity of care.
Our independence
Our approach may be surprising, because it resembles neither curative care nor even traditional check-ups. We are not a care and treatment centre, and we practise neither traditional general medicine, nor specialist medicine, nor the long-term follow-up of chronic conditions. We have no conflict of interest with external healthcare players, and we mobilise no public or hospital resources.
Our project
Put prevention at the heart of all care.
Profoundly transform healthcare systems. The expected result: a rapid and massive drop in care costs, and a considerable increase in healthy life expectancy. Quite simply.